MedTrace Logo

Genetic Evaluation of Men (GEM)

NCT03076242 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 595

Last updated 2025-04-29

No results posted yet for this study

Summary

This is a prospective research registry and prospective genetic testing cohort study. The goal is to collect personal medical and cancer history data, family cancer data, exposure history, and biospecimens to support research focused on optimal genetic testing strategies for men with prostate cancer with the ultimate goal of informing national guidelines focused on genetic evaluation for prostate cancer.

Conditions

Interventions

OTHER

GEM Registry

Men with a personal history of PCA; Unaffected males who are at higher risk for prostate cancer

Sponsors & Collaborators

  • Myriad Genetics, Inc.

    collaborator INDUSTRY

  • Sidney Kimmel Cancer Center at Thomas Jefferson University

    lead OTHER

Principal Investigators

  • Giri Veda, M.D. · Sidney Kimmel Cancer Center at Thomas Jefferson University

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-10-23
Primary Completion
2019-01-15
Completion
2019-05-16

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03076242 on ClinicalTrials.gov